| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 160,666 | 158,408 | 165,576 | 150,362 | | Cost of Revenue | 111,656 | 111,713 | 117,724 | 105,529 | | | Gross Profit | 49,010 | 46,695 | 47,852 | 44,833 | | | Operating Expenses | | Research Development | 6,692 | 7,003 | 6,141 | 6,985 | | Selling General and Administrative | 28,927 | 26,916 | 25,638 | 23,952 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,362 | 1,505 | 1,805 | 2,337 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 12,029 | 11,271 | 14,268 | 11,559 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 101 | 97 | 73 | 97 | | Earnings Before Interest And Taxes | 12,130 | 11,368 | 14,341 | 11,656 | | Interest Expense | 230 | 179 | 193 | 116 | | Income Before Tax | 11,900 | 11,189 | 14,148 | 11,540 | | Income Tax Expense | 2,808 | 2,897 | 1,972 | 914 | | Minority Interest | 60 |
-
| 56 | 40 | | | | Net Income From Continuing Ops | 9,152 | 8,292 | 12,116 | 10,666 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,152 | 8,292 | 12,116 | 10,666 | | Preferred Stock And Other Adjustments | 23 | (23) |
-
|
-
| | | Net Income Applicable To Common Shares | $9,175 | $8,269 | $12,116 | $10,666 |
|
0.01% Nasdaq 
Income Statement
